These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM-regulatory T cells in generalized vitiligo patients. Shah F, Giri PS, Bharti AH, Dwivedi M. Exp Dermatol; 2024 Jan; 33(1):e14982. PubMed ID: 37994568 [Abstract] [Full Text] [Related]
7. Implication of regulatory T cells' telomere shortening in pathogenesis of generalized vitiligo. Giri P, Thakor F, Dwivedi M. Hum Immunol; 2024 Jul; 85(4):110812. PubMed ID: 38755031 [Abstract] [Full Text] [Related]
8. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo. Giri PS, Mistry J, Dwivedi M. J Immunol Res; 2022 Jul; 2022():6952299. PubMed ID: 36164321 [Abstract] [Full Text] [Related]
9. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population. Giri PS, Patel S, Begum R, Dwivedi M. Gene; 2021 Feb 05; 768():145295. PubMed ID: 33181260 [Abstract] [Full Text] [Related]
11. Genetic association of nuclear factor of activated T cells' 3'UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population. Giri P, Bhimani R, Patil S, Dwivedi M. Gene; 2023 Sep 05; 880():147629. PubMed ID: 37429370 [Abstract] [Full Text] [Related]
12. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. Lili Y, Yi W, Ji Y, Yue S, Weimin S, Ming L. PLoS One; 2012 Sep 05; 7(5):e37513. PubMed ID: 22649532 [Abstract] [Full Text] [Related]
15. In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications. Hayashi Y, Ueyama A, Funaki S, Jinushi K, Higuchi N, Morihara H, Hirata M, Nagira Y, Saito T, Kawashima A, Iwahori K, Shintani Y, Wada H. BMC Cancer; 2024 May 23; 24(1):627. PubMed ID: 38783281 [Abstract] [Full Text] [Related]
17. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation. Tembhre MK, Parihar AS, Sharma VK, Sharma A, Chattopadhyay P, Gupta S. Br J Dermatol; 2015 Apr 23; 172(4):940-50. PubMed ID: 25376752 [Abstract] [Full Text] [Related]
18. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells. Jung K, Kim JA, Kim YJ, Lee HW, Kim CH, Haam S, Kim YS. Cancer Immunol Res; 2020 Jan 23; 8(1):46-56. PubMed ID: 31554638 [Abstract] [Full Text] [Related]